loading

Xilio Therapeutics Inc Stock (XLO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
3.55%
17.49
18.13 17.36 20.12 23.53
Operating Income/Loss
3.55%
-17.49
-18.13 -17.36 -20.12 -23.53
Nonoperating Income/Loss
40.21%
0.284
0.475 0.613 0.761 0.88
Income/Loss From Continuing Operations Before Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Income/Loss From Continuing Operations After Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Net Income/Loss
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
135.87K%
27.91
0.0205 27.52 27.47 27.43
Basic Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Diluted Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):